搜索临床试验以:ELGN-2112
总计209个结果
-
Nutrinia未知
-
Precigen, IncNational Cancer Institute (NCI)主动,不招人
-
Promontory Therapeutics Inc.主动,不招人泌尿生殖系统肿瘤 | 按部位分类的肿瘤 | 生殖器肿瘤,男性 | 前列腺肿瘤 | 晚期实体瘤 | mCRPC | 转移性去势抵抗性前列腺癌 | CRPC | PT-112美国, 法国
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Abbott Medical Devices完全的
-
Gunkang Pharmaceuticals, Inc招聘中
-
Vanderbilt-Ingram Cancer CenterAstex Pharmaceuticals, Inc.; Forma Therapeutics, Inc.撤销急性髓性白血病 | 骨髓增生异常综合症 | 复发性急性髓性白血病 | 复发性骨髓增生异常综合征 | 难治性急性髓性白血病 | 难治性骨髓增生异常综合征
-
Affini-T Therapeutics, Inc.招聘中
-
Merck Sharp & Dohme LLC完全的
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Highlight Therapeutics终止
-
Swedish Orphan Biovitrum完全的
-
University of Sao Paulo General HospitalD'Antonio Consultants International, Inc.; Sao Paulo, Secretaria de Estado da Saúde未知
-
ANRS, Emerging Infectious DiseasesEUCLID Clinical Trial Platform招聘中乙型肝炎,慢性法国, 德国, 意大利, 西班牙
-
Yusuf MendaNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden Comprehensive Cancer...尚未招聘
-
Massachusetts General Hospital完全的
-
Inovio Pharmaceuticals完全的